Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gregory

Showing results (1001-1010 of 1,034) with videos related to

Pageof 104
Sort By:
Dementia and Geriatric Cognitive Disorders|August 14, 2019
Soluble Intercellular Adhesion Molecule-1 (sICAM-1) as a Biomarker of Vascular Cognitive Impairment in Older AdultsMichael A Gregory, Leticia Manuel-Apolinar, Sergio Sánchez-Garcia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2010
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working groupPatrick Y Wen, David R Macdonald, David A Reardon, et al.
Metabolic Engineering|November 21, 2012
Recombinant strains for the enhanced production of bioengineered rapalogsSteven G Kendrew, Hrvoje Petkovic, Sabine Gaisser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2013
Rational combination of a MEK inhibitor, selumetinib, and the Wnt/calcium pathway modulator, cyclosporin A, in preclinical models of colorectal cancerAnna Spreafico, John J Tentler, Todd M Pitts, et al.
Nature Communications|January 9, 2016
Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myelomaDavid C Johnson, Niels Weinhold, Jonathan S Mitchell, et al.
The EMBO Journal|June 7, 2018
miR-200/375 control epithelial plasticity-associated alternative splicing by repressing the RNA-binding protein QuakingKatherine A Pillman, Caroline A Phillips, Suraya Roslan, et al.
British Journal of Cancer|August 31, 2024
Altered expression of vesicular trafficking machinery in prostate cancer affects lysosomal dynamics and provides insight into the underlying biology and disease progressionBukuru D Nturubika, Carlos M Guardia, David C Gershlick, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 27, 2008
Summary statement novel agents in the treatment of lung cancer: Fifth Cambridge Conference assessing opportunities for combination therapyThomas J Lynch, George R Blumenschein, Jeffrey A Engelman, et al.
Cancer Cell|January 16, 2007
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patientsTracy T Batchelor, A Gregory Sorensen, Emmanuelle di Tomaso, et al.
The Lancet. Neurology|October 8, 2011
DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational studyGötz Thomalla, Bastian Cheng, Martin Ebinger, et al.
Pageof 104

Showing results (1001-1010 of 1,034) with videos related to

Sort By:
Pageof 104
Dementia and Geriatric Cognitive Disorders|August 14, 2019
Soluble Intercellular Adhesion Molecule-1 (sICAM-1) as a Biomarker of Vascular Cognitive Impairment in Older AdultsMichael A Gregory, Leticia Manuel-Apolinar, Sergio Sánchez-Garcia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2010
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working groupPatrick Y Wen, David R Macdonald, David A Reardon, et al.
Metabolic Engineering|November 21, 2012
Recombinant strains for the enhanced production of bioengineered rapalogsSteven G Kendrew, Hrvoje Petkovic, Sabine Gaisser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2013
Rational combination of a MEK inhibitor, selumetinib, and the Wnt/calcium pathway modulator, cyclosporin A, in preclinical models of colorectal cancerAnna Spreafico, John J Tentler, Todd M Pitts, et al.
Nature Communications|January 9, 2016
Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myelomaDavid C Johnson, Niels Weinhold, Jonathan S Mitchell, et al.
The EMBO Journal|June 7, 2018
miR-200/375 control epithelial plasticity-associated alternative splicing by repressing the RNA-binding protein QuakingKatherine A Pillman, Caroline A Phillips, Suraya Roslan, et al.
British Journal of Cancer|August 31, 2024
Altered expression of vesicular trafficking machinery in prostate cancer affects lysosomal dynamics and provides insight into the underlying biology and disease progressionBukuru D Nturubika, Carlos M Guardia, David C Gershlick, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 27, 2008
Summary statement novel agents in the treatment of lung cancer: Fifth Cambridge Conference assessing opportunities for combination therapyThomas J Lynch, George R Blumenschein, Jeffrey A Engelman, et al.
Cancer Cell|January 16, 2007
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patientsTracy T Batchelor, A Gregory Sorensen, Emmanuelle di Tomaso, et al.
The Lancet. Neurology|October 8, 2011
DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational studyGötz Thomalla, Bastian Cheng, Martin Ebinger, et al.
Pageof 104